← Open Payments lookup

BRANDON ALLEN: Open Payments

NPI 1073091963 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,541 in 27 payments from 11 companies in 2025. Trend: 2023 $433 · 2024 $955 · 2025 $1,541

Food & beverage: $1,541
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$319
Axsome Therapeutics, Inc.2$240
ABBVIE INC.9$187
Supernus Pharmaceuticals, Inc.6$142
Amgen Inc.1$125
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Novo Nordisk Inc1$103
Gilead Sciences, Inc.1$97
VERTEX PHARMACEUTICALS INCORPORATED1$64

Products named: Auvelity, BREZTRI, Qelbree, EVENITY, RELISTOR, CAPLYTA, VRAYLAR, Ozempic.

Industry payments across MS — which companies pay providers there.